<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03230136</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0174</org_study_id>
    <nct_id>NCT03230136</nct_id>
  </id_info>
  <brief_title>Protection During Cardiac Surgery.</brief_title>
  <acronym>ProCCard</acronym>
  <official_title>Protection During Cardiac Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial investigates whether a multimodal cardioprotection per-surgery therapeutic
      strategy could reduce myocardial injury in patients undergoing cardiac surgery compared to
      traditional management. The primary endpoint is the AUC (area under the curve) of the
      hypersensitive troponin I. Blood samples will be collected during the 72 hours following the
      aortic cross-unclamping. This trial is a French, multicenter, randomized, single-blinded and
      controlled trial. 210 patients will be enrolled with a clinical follow-up during 30 days.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the plasma concentration versus time curve (AUC) of Hypersensitive Troponin I</measure>
    <time_frame>at 72 hours</time_frame>
    <description>Area under the plasma concentration versus time curve (AUC) of Hypersensitive Troponin I determined for each patient with the serial measurement from of troponin I assays.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events incidence during the first 30 days following surgery of the multimodal cardioprotection strategy</measure>
    <time_frame>30 days</time_frame>
    <description>Adverse events will include death, myocardial infarction, heart failure, stroke, any infectious event, bleeding events, or surgical complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Troponin I serum peak value</measure>
    <time_frame>72 hours</time_frame>
    <description>Highest serum value recorded for each patient within 72 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Thoracic Surgery</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <arm_group>
    <arm_group_label>Multimodal cardioprotection therapeutic strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional anesthetic and therapeutic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard anesthetic procedure No intervention (Control).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>multimodal cardioprotection strategy</intervention_name>
    <description>Multimodal cardioprotection therapeutic strategy will include (1) remote ischemic preconditioning, (2) volatile anesthetic sevoflurane-induced preconditioning, (3) blood glucose control every 30 minutes during cardiac surgery, (4) temporary respiratory acidosis prior to the aortic cross-unclamping and (5) gradual restoration of blood flow after aortic cross-unclamping (gentle reperfusion).</description>
    <arm_group_label>Multimodal cardioprotection therapeutic strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard anesthetic procedure</intervention_name>
    <description>standard anesthetic procedure will include: anesthesia under propofol throughout the cardiac surgery, blood glucose control every 60 minutes, arterial pH maintained at 7.40, theoric blood flow restored at the earliest after aortic cross-unclamping.</description>
    <arm_group_label>Traditional anesthetic and therapeutic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years old

          -  Aortic valve surgery (aortic valve replacement associated or not with coronary artery
             bypass graft, Bentall surgery or Tirone David surgery)

          -  Signed informed consent

        Exclusion Criteria:

          -  Emergency surgery

          -  Patient treated with Nicorandil or sulfonylurea 48 hours prior to surgery

          -  Low cardiac output requiring catecholamine infusion or circulatory assistance prior to
             surgery

          -  Severe renal failure: dialysis or glomerular filtration rate &lt; 30 mL/min

          -  Severe liver failure (spontaneous INR &gt;2)

          -  Severe respiratory insufficiency (VEMS &lt;40% of predicted value)

          -  Myocardial infarction &lt; 7 days

          -  Severe upper limb arterial disease

          -  Heparin-induced thrombopenia

          -  Active infection under antibiotic treatment

          -  Any other surgery combined with the aortic valve surgery: myotomia of Morrow
             (hypertrophic myocardiopathy), treatment of heart rhythm disorder, inter-atrial
             communication closure, mitral valve replacement, tricuspid valve replacement,
             pulmonary valve replacement.

          -  Pregnant women

          -  Currently participating in another trial which may interfere with ProCCard results

          -  Not benefiting from a social insurance or similar system

          -  Patient under legal protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc FELLAHI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Luc FELLAHI, MD</last_name>
    <phone>4 72 11 89 33</phone>
    <phone_ext>+33</phone_ext>
    <email>jean-luc.fellahi@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pascal CHIARI, MD</last_name>
    <phone>4 72 11 89 33</phone>
    <phone_ext>+33</phone_ext>
    <email>pascal.chiari@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH Annecy</name>
      <address>
        <city>Annecy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascale BLANC, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pascale BLANC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthésie-Réanimation, Hôpital Cardiologique et Pneumologique Louis Pradel</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Luc FELLAHI, MD</last_name>
      <phone>4 72 11 89 33</phone>
      <phone_ext>+33</phone_ext>
      <email>jean-luc.fellahi@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pascal CHIARI, MD</last_name>
      <phone>4 72 11 89 33</phone>
      <phone_ext>+33</phone_ext>
      <email>pascal.chiari@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Luc FELLAHI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal CHIARI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>service de Chirurgie Cardiaque CHU Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne MEDARD, MD</last_name>
      <email>amedard@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Anne MEDARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unité de Réanimation Cardiovasculaire et Thoracique, Hôpital Michallon</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michel DURAND, MD</last_name>
      <email>MDurand@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Michel DURAND, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Arnault Tzanck - Saint-Laurent du Var</name>
      <address>
        <city>Saint-Laurent-du-Var</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diane LENA-QUINTARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Diane LENA-QUINTARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Saint-Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalie GRAND, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nathalie GRAND, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2017</study_first_submitted>
  <study_first_submitted_qc>July 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2017</study_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myocardial injury</keyword>
  <keyword>Ischemia reperfusion</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>cardioprotection</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

